Zymeworks Inc.
ZYME
$12.25
-$0.30-2.39%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 93.94% | -16.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 93.94% | -16.85% | |||
| Cost of Revenue | 1.95% | 24.65% | |||
| Gross Profit | 70.36% | -105.17% | |||
| SG&A Expenses | 16.84% | -11.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.06% | 11.96% | |||
| Operating Income | 35.05% | -33.62% | |||
| Income Before Tax | 39.94% | 21.25% | |||
| Income Tax Expenses | 2,428.76% | 232.35% | |||
| Earnings from Continuing Operations | 21.25% | 20.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.25% | 20.79% | |||
| EBIT | 35.05% | -33.62% | |||
| EBITDA | 40.30% | -35.87% | |||
| EPS Basic | 19.71% | 20.51% | |||
| Normalized Basic EPS | 38.77% | -46.24% | |||
| EPS Diluted | 19.84% | 20.51% | |||
| Normalized Diluted EPS | 38.79% | -46.18% | |||
| Average Basic Shares Outstanding | -1.93% | -0.35% | |||
| Average Diluted Shares Outstanding | -1.89% | -0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
